Confronto

Semax vs. Teduglutid

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

80714-61-0

197922-42-2

Peso molecolare

813.92 g/mol

3752.13 g/mol

Emivita

0.3 h

nessun dato

Sequenza

Met-Glu-His-Phe-Pro-Gly-Pro

nessun dato

Meccanismo d'azione

Semax

Semax is a tetracosactide fragment analog without hormonal activity at MC2R. Proposed mechanisms include elevation of BDNF and NGF in hippocampus and striatum (in animal models), modulation of dopamine metabolism, and neuroprotective effects via anti-apoptotic pathways. A clear primary receptor is not established.

Teduglutid

Teduglutide activates the GLP-2 receptor, promoting growth and regeneration of small-intestinal villi, increasing nutrient and fluid absorption and thereby reducing dependence on parenteral nutrition. The glycine substitution at position 2 makes it resistant to rapid breakdown by DPP-4.

Base di evidenze

Evidenza più alta

Studio sull'uomo

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Semax	Teduglutid
Germania	Non approvato	Su prescrizione
RU	Su prescrizione	—
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Semax and Teduglutid?: Semax is classified as "Ricerca (altro)", while Teduglutid is classified as "Ricerca (altro)". Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Semax or Teduglutid?: The highest available evidence level is "Studio sull'uomo" for Semax and "RCT sull'uomo" for Teduglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Semax and Teduglutid in Germany and the United States?: Germania: Semax — Non approvato, Teduglutid — Su prescrizione. Stati Uniti: Semax — Non approvato, Teduglutid — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Semax

Teduglutid

Germania

Non approvato

Su prescrizione

—

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Semax and Teduglutid?

Semax is classified as "Ricerca (altro)", while Teduglutid is classified as "Ricerca (altro)". Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Semax or Teduglutid?

The highest available evidence level is "Studio sull'uomo" for Semax and "RCT sull'uomo" for Teduglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Semax and Teduglutid in Germany and the United States?

Germania: Semax — Non approvato, Teduglutid — Su prescrizione. Stati Uniti: Semax — Non approvato, Teduglutid — Su prescrizione. These are factual summaries with source and review date on the individual pages.